angiopeptin (cas 113294-82-9), the octapeptide analogue of somatostatin, decreases rat heart endothelial cell adhesiveness for mononuclear cells
-
Add time:08/16/2019 Source:sciencedirect.com
The effect of angiopeptin, a stable analogue of somatostatin, was studied on basal and interleukin-1-β-induced endothelial cell adhesiveness for mononuclear cells, and compared to the effect of somatostatin. Angiopeptin and somatostatin decreased basal and interleukin-1-β-induced endothelial cell adhesiveness for mononuclear cells. The decreased mononuclear cells adhesion to endothelial cells exposed to angiopeptin and somatostatin is not due to modulation of the expression of intrecellular adhesion molecule-1 because neither angiopeptin nor somatostatin decreased basal and interleukin-1-β-induced expression of this adhesion molecule. The effect of angiopeptin in inhibiting endothelial cell adhesiveness for mononuclear cells was abolished by addition of dibutyryl-cyclic AMP. Angiopeptin induced a transient decrease in basal and interleukin-1-β-induced cyclic AMP levels in endothelial cells. Exposure of unstimulated and interleukin-1-β-activated endothelial cells to KT5720, a specific inhibitor of cyclic AMP-dependent protein kinase, decreased endothelial cell adhesiveness for mononuclear cells. Thus, angiopeptin most likely diminishes endothelial adhesiveness for mononuclear cells by affecting the cyclic AMP-dependent protein kinase signal transduction pathway.The findings suggest that angiopeptin and somatostatin may modify the development of the immune response by attenuating endothelial cell adhesiveness for mononuclear cells. Angiopeptin may have a potential clinical application as a modulator of some aspects of the immune response due to its long half-life and prolonged inhibitory effect on interleukin-1-β induced endothelial adhesiveness for mononuclear cells.
We also recommend Trading Suppliers and Manufacturers of angiopeptin (cas 113294-82-9). Pls Click Website Link as below: cas 113294-82-9 suppliers
Prev:Early inhibition of myointimal proliferation by angiopeptin (cas 113294-82-9) after balloon catheter injury in the rabbit☆☆☆★
Next:Allograft vasculopathyShort-term angiopeptin (cas 113294-82-9) therapy and the incidence of graft vessel disease after heart transplantation) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- angiopeptin (cas 113294-82-9), a Somatostatin Analogue, Inhibits Rat Coronary Artery and Aorta Smooth Muscle Cell Proliferation Induced by the Thromboxane A2 Mimetic U4661908/18/2019
- Allograft vasculopathyShort-term angiopeptin (cas 113294-82-9) therapy and the incidence of graft vessel disease after heart transplantation08/17/2019
- Early inhibition of myointimal proliferation by angiopeptin (cas 113294-82-9) after balloon catheter injury in the rabbit☆☆☆★08/15/2019
- Research paperInhibition of coronary artery transplant atherosclerosis in rabbits with angiopeptin (cas 113294-82-9), an octapeptide08/14/2019
- Research paperInhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin (cas 113294-82-9) and BIM 23034☆08/13/2019
- Research paperIntranasal absorption of different aqueous formulations of angiopeptin (cas 113294-82-9): In vivo bioavailability study08/12/2019


